November 2008 - Volume 3 - Issue 6 - Contributor Index

View All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z Other
Actions
View
Show
Previous of 2 Next
Author Name Article
Bernstein, Wendy B

Repositioning HIV protease inhibitors as cancer therapeutics

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Blaschke, Terrence F

Variable adherence to prescribed dosing regimens for protease inhibitors: scope and outcomes

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Boesecke, Christoph

Toxicity of HIV protease inhibitors: clinical considerations

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Boucher, Charles AB

Novel mechanisms of HIV protease inhibitor resistance

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Burger, David

Clinical pharmacology of HIV protease inhibitors in pregnancy

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Chan-Tack, Kirk M

Regulatory issues in developing new HIV protease inhibitors: risks and benefits

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Colbers, Angela

Clinical pharmacology of HIV protease inhibitors in pregnancy

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Cooper, David A

Toxicity of HIV protease inhibitors: clinical considerations

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Dennis, Phillip A

Repositioning HIV protease inhibitors as cancer therapeutics

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Eissenstat, Michael

Approaches to the design of HIV protease inhibitors with improved resistance profiles

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Elliott, Julian H

Protease inhibitor therapy in resource-limited settings

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Gulnik, Sergei V

Approaches to the design of HIV protease inhibitors with improved resistance profiles

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Hruz, Paul W

HIV protease inhibitors and insulin resistance: lessons from in-vitro, rodent and healthy human volunteer models

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Khoo, Saye

Clinical application of the inhibitory quotient: is there a role in HIV protease inhibitor therapy?

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Nalam, Madhavi NL

New approaches to HIV protease inhibitor drug design II: testing the substrate envelope hypothesis to avoid drug resistance and discover robust inhibitors

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Nijhuis, Monique

Novel mechanisms of HIV protease inhibitor resistance

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Pujari, Sanjay

Protease inhibitor therapy in resource-limited settings

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Schiffer, Celia A

New approaches to HIV protease inhibitor drug design II: testing the substrate envelope hypothesis to avoid drug resistance and discover robust inhibitors

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Soon, Guoxing (Greg)

Regulatory issues in developing new HIV protease inhibitors: risks and benefits

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Struble, Kimberly A

Regulatory issues in developing new HIV protease inhibitors: risks and benefits

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Actions
View
Show
Previous of 2 Next